BioMarin Holds Investor Day

Provides New Corporate Strategy and Introduces 2027 Financial Guidance BioMarin is an international biotech firm with a portfolio of eight products designed to address life-threatening diseases. Since our inception in 1997, we have leveraged our deep scientific knowledge of genetic disorders to develop breakthrough therapies, utilizing various treatment approaches. Our approved drugs provide solutions for … Read more